Health Conditions
Allergy
Anaphylaxis
Food Allergy
Seasonal Allergy
Blood Health
Anemia
Sickle Cell Disease
Cancer
Cancer Screenings and Prevention
Digestion Health
C Difficile Infection
Gastroesophageal Reflux Disease (GERD)
Inflammatory Bowel Disease
Irritable Bowel Syndrome
Peptic Ulcer
Ulcerative Colitis
Endocrine Health
Cushing Syndrome
Thyroid Disorders
Type 1 Diabetes
Type 2 Diabetes
Eye Health
Age-Related Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy
Geographic Atrophy
Uveitis
Heart Health
Arrhythmia
Atherosclerotic Cardiovascular Disease
Dyslipidemia
Heart Failure
Hypertension
Stroke
Structural Heart Disease
Venous Thromboembolism
Hormone Health
Hormonal Disorders
Infectious Disease
COVID-19
HIV/AIDS
Influenza
Respiratory Syncytial Virus
Joint Health
Ankylosing Spondylitis
Fibromyalgia
Gout
Lupus
Non-Radiographic Axial Spondyloarthritis
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Rheumatoid Arthritis
Spondyloarthritis
Kidney Health
C3 Glomerulopathy
Chronic Kidney Disease
IgA Nephropathy
Liver And Pancreas Health
Alpha-1 Antitrypsin Deficiency
Hepatitis C
MASH
MASLD
Primary Biliary Cholangitis
Lung Health
Asthma
COPD
Lung Cancer
Pulmonary Fibrosis
Men's Health
Benign Prostatic Hyperplasia
Erectile Dysfunction
Low Testosterone
Mental Health
ADHD
Addiction
Bipolar Disorder
Major Depressive Disorder
PTSD
Schizophrenia
Neurologic Disorders
Alzheimer Disease
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Migraine
Multiple Sclerosis
Myasthenia Gravis
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Parkinson's Disease
Spinal Muscular Atrophy
Stiff-Person Syndrome
Tardive Dyskinesia
Traumatic Brain Injury
Pain
Acute Pain
Chronic Pain
Neuropathic Pain
Rare Diseases
Amyloidosis
Huntington Disease
Lysosomal Storage Disorders
Vasculitis
Sexual Health
Sexually Transmitted Infections
Skin Health
Acne
Atopic Dermatitis
Chronic Idiopathic Urticaria
Plaque Psoriasis
Rosacea
Vitiligo
Sleep Health
Insomnia
Obstructive Sleep Apnea
Weight Management
Obesity
Women's Health
Endometriosis
Menopause
Polycystic Ovary Syndrome
News
About
logo
Allergy
Anaphylaxis
Food Allergy
Seasonal Allergy
Blood Health
Anemia
Sickle Cell Disease
Cancer
Cancer Screenings and Prevention
Digestion Health
C Difficile Infection
Gastroesophageal Reflux Disease (GERD)
Inflammatory Bowel Disease
Irritable Bowel Syndrome
Peptic Ulcer
Ulcerative Colitis
Endocrine Health
Cushing Syndrome
Thyroid Disorders
Type 1 Diabetes
Type 2 Diabetes
Eye Health
Age-Related Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy
Geographic Atrophy
Uveitis
Heart Health
Arrhythmia
Atherosclerotic Cardiovascular Disease
Dyslipidemia
Heart Failure
Hypertension
Stroke
Structural Heart Disease
Venous Thromboembolism
Hormone Health
Hormonal Disorders
Infectious Disease
COVID-19
HIV/AIDS
Influenza
Respiratory Syncytial Virus
Joint Health
Ankylosing Spondylitis
Fibromyalgia
Gout
Lupus
Non-Radiographic Axial Spondyloarthritis
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Rheumatoid Arthritis
Spondyloarthritis
Kidney Health
C3 Glomerulopathy
Chronic Kidney Disease
IgA Nephropathy
Liver And Pancreas Health
Alpha-1 Antitrypsin Deficiency
Hepatitis C
MASH
MASLD
Primary Biliary Cholangitis
Lung Health
Asthma
COPD
Lung Cancer
Pulmonary Fibrosis
Men's Health
Benign Prostatic Hyperplasia
Erectile Dysfunction
Low Testosterone
Mental Health
ADHD
Addiction
Bipolar Disorder
Major Depressive Disorder
PTSD
Schizophrenia
Neurologic Disorders
Alzheimer Disease
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Migraine
Multiple Sclerosis
Myasthenia Gravis
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Parkinson's Disease
Spinal Muscular Atrophy
Stiff-Person Syndrome
Tardive Dyskinesia
Traumatic Brain Injury
Pain
Acute Pain
Chronic Pain
Neuropathic Pain
Rare Diseases
Amyloidosis
Huntington Disease
Lysosomal Storage Disorders
Vasculitis
Sexual Health
Sexually Transmitted Infections
Skin Health
Acne
Atopic Dermatitis
Chronic Idiopathic Urticaria
Plaque Psoriasis
Rosacea
Vitiligo
Sleep Health
Insomnia
Obstructive Sleep Apnea
Weight Management
Obesity
Women's Health
Endometriosis
Menopause
Polycystic Ovary Syndrome
News
About
Advertisement
facebooktwitterlinkedin
Health Resources Hub / Kidney Health / Chronic Kidney Disease

The Growing Link Between High BMI and Chronic Kidney Disease

High body weight now accounts for more than a quarter of CKD deaths worldwide, according to new research.

Advertisement
Advertisement
facebooktwitterlinkedin

By

Lana Pine

 |  Published on August 13, 2025

4 min read

The Growing Link Between High BMI and Chronic Kidney Disease

Credit: Adobe Stock/Ralf Kalytta

Chronic kidney disease (CKD) affects millions of people worldwide and can lead to serious health problems, including kidney failure. A new global study has found that while CKD rates have been gradually increasing for decades, kidney problems linked specifically to high body weight are growing much faster — and are projected to keep climbing until at least 2050.

According to the American Kidney Fund (AKF), an estimated 35.5 million people in the United States alone have kidney disease, making it the country’s fastest-growing noncommunicable disease. Maintaining a healthy weight, staying active, following a kidney-friendly diet and getting tested for kidney disease are all key steps for prevention.

A body mass index (BMI) of 25 or higher is considered overweight, and 30 or higher is considered obese. Excess weight can put extra strain on the kidneys, increasing the risk of CKD over time.

“Epidemiologically, quantifying the disease burden associated with modifiable risk factors such as obesity is essential for understanding its relationship with CKD,” wrote lead investigator Weihong Zhao, of the division of nephrology at Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital in China. “However, CKD burden attributable to obesity, especially in epidemiological patterns and dynamic changes, remains unclear.”

Zhao and team analyzed data from 204 countries covering the years 1990 to 2021 from the Global Burden of Disease (GBD) Study 2021. They focused on CKD cases, deaths and years of healthy life lost (called disability-adjusted life years, or DALYs) related specifically to high BMI.

What the Study Found

In 2021, CKD caused over 1.5 million deaths globally. Nearly 420,000 of those deaths — about 27% — were linked to high BMI. High BMI was also responsible for more than 10.4 million DALYs.

When comparing 1990 with 2021, deaths from CKD related to high BMI increased 3.5 times, and DALYs nearly tripled. The rise was seen in both men and women, but men had slightly faster growth rates.

Looking Ahead

The study projects that CKD deaths and disability linked to high BMI will continue to rise steadily through 2050. While men and women are expected to have similar rates, the total number of cases will likely be higher among women.

Investigators also looked at why CKD rates are climbing. They found that population aging, growth and changes in disease patterns all play a role. Aging, in particular, has a big impact in higher-income regions.

By taking steps to keep your weight in a healthy range, you can reduce the strain on your kidneys and lower your risk of developing CKD. With obesity rates climbing worldwide, this study is a wake-up call for both individuals and public health systems to take action.

Investigators mentioned some important limitations, including basing the findings on observational data, as they can’t prove that high body weight directly causes CKD. It also only used BMI to measure obesity, which doesn’t distinguish between muscle and fat or show where fat is stored in the body. In some countries, limited health care resources may lead to missed or incorrect CKD diagnoses, meaning the true number of cases could be higher. In addition, the CKD diagnosis was based on estimated kidney function tests that may be less accurate in certain populations.

“Given that obesity is a modifiable risk factor, targeted weight reduction policies and interventions tailored to specific age groups, sexes, and regional contexts should be encouraged in the future,” concluded investigators.

Related Videos

More on Chronic Kidney Disease

Person with heart failure experiencing chest pain. | Credit: Adobe Stock

FDA Approves New Option for Difficult-to-Treat Heart Failure

Doctor checking the heart beat of a patient with type 2 diabetes inside of an exam room. | Credit: Adobe Stock/By Nina/peopleimages.com

Two Is Better Than One: Study Backs Early Combo for Kidney and Heart Health in Diabetes

What Your Bathroom Habits Might Be Telling You, with Alexander Kandabarow, M.D.

What Your Bathroom Habits Might Be Telling You, with Alexander Kandabarow, M.D.

Related Content

Poor Sleep and Kidney Function Could Drive Severe Liver DiseasePoor Sleep and Kidney Function Could Drive Severe Liver Disease

Data show patients with poor sleep health and the high biomarker scores for renal function were nearly six times more likely to develop MASLD.

Credit: Centre for Advancing Health OutcomesNew Tool Helps Predict How Pediatric IgA Nephropathy Will Progress After a Biopsy

This new tool can help doctors identify children who are at risk of having their kidney function worsen or developing end-stage kidney disease (ESKD) within two years after a biopsy.

IgA Vasculitis Linked to Worse Dialysis, Mortality Outcomes than IgA NephropathyIgA Vasculitis Linked to Worse Dialysis, Mortality Outcomes than IgA Nephropathy

Research suggests there are clear differences in clinical outcomes and severities between IgAN and IgAV.

Poor Sleep and Kidney Function Could Drive Severe Liver DiseasePoor Sleep and Kidney Function Could Drive Severe Liver Disease

Data show patients with poor sleep health and the high biomarker scores for renal function were nearly six times more likely to develop MASLD.

Credit: Centre for Advancing Health OutcomesNew Tool Helps Predict How Pediatric IgA Nephropathy Will Progress After a Biopsy

This new tool can help doctors identify children who are at risk of having their kidney function worsen or developing end-stage kidney disease (ESKD) within two years after a biopsy.

IgA Vasculitis Linked to Worse Dialysis, Mortality Outcomes than IgA NephropathyIgA Vasculitis Linked to Worse Dialysis, Mortality Outcomes than IgA Nephropathy

Research suggests there are clear differences in clinical outcomes and severities between IgAN and IgAV.

Poor Sleep and Kidney Function Could Drive Severe Liver DiseasePoor Sleep and Kidney Function Could Drive Severe Liver Disease

Data show patients with poor sleep health and the high biomarker scores for renal function were nearly six times more likely to develop MASLD.

Credit: Centre for Advancing Health OutcomesNew Tool Helps Predict How Pediatric IgA Nephropathy Will Progress After a Biopsy

This new tool can help doctors identify children who are at risk of having their kidney function worsen or developing end-stage kidney disease (ESKD) within two years after a biopsy.

Advertisement
Advertisement
Contact Us and Policies
About The Educated PatientContact UsPrivacy PolicyTerms of UseDo Not Sell My Information
Follow on Social Media
facebookinstagramlinkedintwitter